Improving Influenza Vaccination in Children With Comorbidities: A Systematic Review

Daniel A Norman1,2, Rosanne Barnes3, Rebecca Pavlos3

  • 1Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia; daniel.norman@telethonkids.org.au.

Pediatrics
|February 9, 2021
PubMed

Insights

Influenza vaccination coverage in children with medical conditions improved with reminders and education, but effectiveness varied. More research is needed to identify optimal strategies for these high-risk children.

Area of Science:

  • Pediatrics
  • Public Health
  • Vaccinology

Background:

  • Children with medical comorbidities face higher risks of severe influenza and adverse outcomes.
  • Despite existing recommendations and funding, influenza vaccine uptake remains insufficient in this vulnerable pediatric population.

Purpose of the Study:

  • To systematically review interventions aimed at improving influenza vaccine coverage in children with comorbidities.
  • To assess the impact of these interventions on influenza vaccination rates.

Main Methods:

  • A comprehensive literature search was conducted across multiple major databases (PubMed, Scopus, Embase, CINAHL, Cochrane, AMED, Web of Science).
  • Studies focusing on interventions for influenza vaccination in children with medical comorbidities were selected.
  • Data extraction and risk of bias assessment were performed independently by multiple reviewers.

Main Results:

  • Out of 961 screened articles, 35 met the inclusion criteria.
  • Interventions including vaccination reminders, parent/provider education, and clinic process changes significantly improved influenza vaccine coverage by an average of 60%.
  • No significant differences in coverage were found between different intervention types, with notable study bias and heterogeneity.

Conclusions:

  • Interventions consistently enhance influenza vaccine coverage in children with comorbidities.
  • The study identified a high risk of bias and low evidence quality, limiting definitive conclusions on intervention effectiveness.
  • Further well-designed research is necessary to determine the most effective interventions for optimizing influenza vaccination in this population.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
49.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
580
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
102
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
260